266 related articles for article (PubMed ID: 28139534)
41. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
[TBL] [Abstract][Full Text] [Related]
42. p53 codon 72 polymorphism and HPV status in lung cancer.
Buyru N; Altinisik J; Isin M; Dalay N
Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
[TBL] [Abstract][Full Text] [Related]
43. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
Kumari A; Bahl C; Singh N; Behera D; Sharma S
Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
[TBL] [Abstract][Full Text] [Related]
44. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.
Høgdall EV; Høgdall CK; Christensen L; Glud E; Blaakaer J; Bock JE; Vuust J; Nørgaard-Pedersen B; Kjaer SK
Anticancer Res; 2002; 22(3):1859-64. PubMed ID: 12168882
[TBL] [Abstract][Full Text] [Related]
45. Association of specific genotype and haplotype of p53 gene with cervical cancer in India.
Mitra S; Misra C; Singh RK; Panda CK; Roychoudhury S
J Clin Pathol; 2005 Jan; 58(1):26-31. PubMed ID: 15623478
[TBL] [Abstract][Full Text] [Related]
46. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.
Baek WK; Cho JW; Suh SI; Suh MH; Shin DH; Cho CH; Lee TS; Cha SD
J Korean Med Sci; 2000 Feb; 15(1):65-7. PubMed ID: 10719811
[TBL] [Abstract][Full Text] [Related]
47. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
[TBL] [Abstract][Full Text] [Related]
48. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
[TBL] [Abstract][Full Text] [Related]
49. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes.
Papadakis ED; Soulitzis N; Spandidos DA
Br J Cancer; 2002 Oct; 87(9):1013-8. PubMed ID: 12434294
[TBL] [Abstract][Full Text] [Related]
50. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women.
Bhattacharya P; Duttagupta C; Sengupta S
Cancer Lett; 2002 Dec; 188(1-2):207-11. PubMed ID: 12406566
[TBL] [Abstract][Full Text] [Related]
51. p53 codon 72 polymorphism and its association with bladder cancer.
Soulitzis N; Sourvinos G; Dokianakis DN; Spandidos DA
Cancer Lett; 2002 May; 179(2):175-83. PubMed ID: 11888672
[TBL] [Abstract][Full Text] [Related]
52. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
54. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
[TBL] [Abstract][Full Text] [Related]
55. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer.
Aydin M; Bozkurt A; Cikman A; Gulhan B; Karabakan M; Gokce A; Alper M; Kara M
Int Braz J Urol; 2017; 43(1):36-46. PubMed ID: 28124524
[TBL] [Abstract][Full Text] [Related]
56. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
57. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
[TBL] [Abstract][Full Text] [Related]
58. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419
[TBL] [Abstract][Full Text] [Related]
59. Helicobacter pylori infection and a P53 codon 72 single nucleotide polymorphism: a reason for an unexplained Asian enigma.
Pandey R; Misra V; Misra SP; Dwivedi M; Misra A
Asian Pac J Cancer Prev; 2014; 15(21):9171-6. PubMed ID: 25422197
[TBL] [Abstract][Full Text] [Related]
60. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
